Exair® Versus Native Tissue Repair for Prolapse
Stopped early
Conditions studied: Pelvic Organ Prolapse
In brief
The purpose of this study is to compare safety and effectiveness of the Exair Prolapse Repair System for treatment of pelvic organ prolapse to traditional native tissue repair through 36 months of follow-up.
Key facts
- Study ID
- NCT02162628
- Run by
- Coloplast A/S
- People needed
- 79
- Starts
- 2014-08-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2015-12-14
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female at least 18 years of age
- Subject has pelvic organ prolapse with leading edge at or beyond the hymen. At or beyond the hymen is defined as POP-Q scores of Ba ≥0 and Bp ≥0 and C≥ -1/2 tvl
- Subject reports a bothersome bulge they can see or feel per PFDI-20 question 3, response of 2 or higher (i.e. responses of "somewhat", "moderately" or "quite a bit")
- Subject is willing to provide written informed consent
- Subject is willing and able to comply with the follow-up regimen
You may not qualify if…
- Subject is pregnant or intends to become pregnant during the study
- Subject has an active or chronic systemic infection including any gynecologic infection, untreated urinary tract infection (UTI), or tissue necrosis
- Subject has a history of pelvic organ cancer (e.g. uterine, ovarian, bladder, or cervical)
- Subject has had prior or is currently undergoing radiation, laser therapy, or chemotherapy in the pelvic area
- Subject has taken systemic steroids (within the last month), or immunosuppressive or immunomodulatory treatment (within the last 3 months)
- Subject has a systemic connective tissue disease (e.g. scleroderma, systemic lupus erythematosus (SLE), Marfan syndrome, Ehlers Danlos, collagenosis, polymyositis or polymyalgia rheumatica)
- Subject has chronic systemic pain that includes the pelvic area or chronic focal pain that involves the pelvis
- Subject has uncontrolled diabetes mellitus (DM)
- Subject has a known neurologic or medical condition affecting bladder function (e.g. multiple sclerosis, spinal cord injury, or stroke with residual neurologic deficit)
- Subject is seeking obliterative vaginal surgery as treatment for pelvic organ prolapse (colpocleisis)
- Subject is not able to conform to the modified dorsal lithotomy position
- Subject is currently participating in or plans to participate in another device or drug study during this study
- Subject has a known sensitivity to polypropylene
- Subject has had previous prolapse repair with mesh in the target compartment(s)
Where it is running
- Progressive GYN Center — Savannah, Georgia, United States
- Women's Health Advantage — Fort Wayne, Indiana, United States
- Advanced Urogynecology of Michigan — Dearborn, Michigan, United States
- Minnesota Women's Care — Maplewood, Minnesota, United States
- Atlantic Urogynecology Associates — Morristown, New Jersey, United States
- Princeton Urogynecology — Princeton, New Jersey, United States
- Albany Medical Center — Albany, New York, United States
- United Health Services — Johnson City, New York, United States
- Lyndhurst Clinical Research — Winston-Salem, North Carolina, United States
- Novant Health Clinical Research — Winston-Salem, North Carolina, United States
- The Institute for Female Pelvic Medicine and Reconstructive Surgery — Allentown, Pennsylvania, United States
- Vermont Urogynecology Associates, P.C. — Williston, Vermont, United States
- Carillion Clinic OB/GYN — Christiansburg, Virginia, United States
- CHUS-CRC — Sherbrooke, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.